Somaxon's Silenor Gains An FDA Approval, But Can The Pharma Afford A Launch?
This article was originally published in The Pink Sheet Daily
Executive Summary
Somaxon hopes to launch its insomnia drug in the second half of 2010, but is still searching for a U.S. commercial partner.
You may also be interested in...
Somaxon Sees “Clear Path” For Silenor Sleep Aid Switch
Somaxon Pharmaceuticals expects to make Silenor sleep aid available OTC in five to seven years.
Somaxon Sees “Clear Path” For Silenor Sleep Aid Switch
Somaxon Pharmaceuticals expects to make Silenor sleep aid available OTC in five to seven years.
Back In The Game: One Year After Rx Exit, P&G Signs On To Promote Silenor
Somaxon and P&G are preparing to launch the insomnia drug in September with a combined sales force of 215 reps.